NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer’s Disease Read more
Pfizer’s Zavicefta matches standard-of-care in treating hospital-acquired pneumonia in phase 3 study Read more